The Musculoskeletal Tumor Society Clinical Practice Guideline on the Management of Metastatic Humeral Disease
Nicholas Tedesco, NathanW. Mesko, Felasfa M. Wodajo, Management of Metastatic Humeral Disease Work Group Mesko Nate MD Tedesco Nicholas DO Belzarena Cecilia MD Christ Alexander B. MD Colman Matthew MD Doung Yee-Cheen MD Ghert Michelle MD, FRCSC Gurich Trey MD Houdek Matthew T. MD Ramkumar Dipak B. MD, MS Siegel Geoffrey W. MD Thorpe Steve MD, FACS Wallace Matthew T. MD, MBA Wodajo Felasfa MD Murray Jayson MA Schulte Danielle MS, EMBA Weintraub Elizabeth MPH Verity Tyler Jebamony Kevin MPH Mink Kerri L.
Abstract
Management of Metastatic Humeral Disease is based on a systematic review of published studies surrounding the management of metastatic disease, multiple myeloma, and lymphoma limited to the humerus. This guideline contains seven action statements to assist orthopaedic surgeons, orthopaedic oncologists, physicians, and any other qualified healthcare professionals involved in the surgical management of metastatic disease of the humerus. It is also intended to serve as an information resource for decision makers, researchers, and developers of clinical practice guidelines. In addition to providing pragmatic practice recommendations, this guideline also highlights gaps in the literature and informs areas for future research and quality measure development. This guideline has been endorsed by the American Academy of Orthopaedic Surgeons.